
Mar 31, 2025, 12:30
Myeloma Paper of the Day, March 31st, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of outcomes in myeloma patients undergoing ASCT after suboptimal pretransplant response (<VGPR) finds median PFS and OS were 38.6 (95% confidence interval [CI], 35.9–41.9) months and 103.8 (95% CI, 96.4–113.2) months.”
Authors: Oren Pasvolsky, Muhammad Bilal Abid, Denái Milton, Mark Tanner, Qaiser Bashir, Sheeba Thomas, Robert Orlowski, Richard Champlin, Elizabeth Shpall, Muzaffar Qazilbash et al.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53